An Chen
Impact in
- Geriatrics and Gerontology top 2%
- Sirtuins and Resveratrol in Medicine
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
Papers in
-
- RNA modifications and cancer 3
-
- Ferroptosis and cancer prognosis 4
- Co-authors
- Jianyun Yan (17 shared papers)Qingchun Liang (15 shared papers)Yining Li (11 shared papers)Zirong Lan (16 shared papers)Yuanzhi Ye (15 shared papers)Xiaoyu Liu (10 shared papers)Lihe Lu (8 shared papers)Qianqian Dong (10 shared papers)
- Journals
- The FASEB Journal (3 papers)European Journal of Pharmacology (3 papers)Acta Pharmaceutica Sinica B (2 papers)PLoS ONE (2 papers)Molecular Pharmaceutics (2 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
An Chen
72 papers receiving 1.6k citations
An Chen's Hit Papers
Peers
Comparison fields: 5 of 115
- Geriatrics and Gerontology 149
- Cancer Research 204
- Nephrology 92
- Immunology 215
- Physiology 46
Countries citing papers authored by An Chen
This map shows the geographic impact of An Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by An Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites An Chen more than expected).
Fields of papers citing papers by An Chen
This network shows the impact of papers produced by An Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by An Chen. The network helps show where An Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside An Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Repression of the antiporter SLC7A11/glutathione/glutathione peroxidase 4 axis drives ferroptosis of vascular smooth muscle cells to facilitate vascular calcification Hit paper breakdown → | 2022 | 265 |
| 2 | 2009 | 237 | |
| 3 | 2008 | 93 | |
| 4 | 2004 | 90 | |
| 5 | 2021 | 75 | |
| 6 | 2004 | 66 | |
| 7 | 2023 | 47 | |
| 8 | 2021 | 46 | |
| 9 | 2022 | 40 | |
| 10 | 2012 | 37 | |
| 11 | 2005 | 35 | |
| 12 | 2015 | 32 | |
| 13 | 2016 | 27 | |
| 14 | 2002 | 27 | |
| 15 | 2018 | 26 | |
| 16 | 2021 | 26 | |
| 17 | 2020 | 26 | |
| 18 | 2022 | 25 | |
| 19 | 2022 | 23 | |
| 20 | 2004 | 22 |
About An Chen
An Chen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Immunology and Complementary and alternative medicine, having authored 76 papers that have together received 1.6k indexed citations. Recurring topics across this work include Crystallography and molecular interactions (4 papers), Ferroptosis and cancer prognosis (4 papers), Endoplasmic Reticulum Stress and Disease (4 papers), Cancer-related molecular mechanisms research (3 papers), RNA modifications and cancer (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Crystallization and Solubility Studies (3 papers) and Sirtuins and Resveratrol in Medicine (3 papers). The work is most often cited by research in Geriatrics and Gerontology (149 citations), Cancer Research (204 citations), Nephrology (92 citations), Immunology (215 citations) and Physiology (46 citations). An Chen has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Jianyun Yan, Qingchun Liang, Yining Li, Zirong Lan, Yuanzhi Ye, Xiaoyu Liu, Lihe Lu, Qianqian Dong, Mingwei Fu and Deyu Fang. Their work appears in journals such as The FASEB Journal, European Journal of Pharmacology, Acta Pharmaceutica Sinica B, PLoS ONE and Molecular Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.